A detailed history of Zeke Capital Advisors, LLC transactions in Danaher Corp stock. As of the latest transaction made, Zeke Capital Advisors, LLC holds 7,239 shares of DHR stock, worth $1.66 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
7,239
Previous 3,809 90.05%
Holding current value
$1.66 Million
Previous $984,000 95.22%
% of portfolio
0.13%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$241.42 - $282.29 $828,070 - $968,254
3,430 Added 90.05%
7,239 $1.92 Million
Q3 2022

Nov 14, 2022

SELL
$247.06 - $1507.4 $23,964 - $146,217
-97 Reduced 2.48%
3,809 $984,000
Q2 2022

Aug 09, 2022

BUY
$237.11 - $299.66 $141,554 - $178,897
597 Added 18.04%
3,906 $990,000
Q1 2022

May 13, 2022

BUY
$257.27 - $315.76 $851,306 - $1.04 Million
3,309 New
3,309 $971,000
Q1 2020

Apr 24, 2020

SELL
$121.39 - $169.05 $1.38 Million - $1.92 Million
-11,383 Closed
0 $0
Q4 2019

Jan 17, 2020

SELL
$133.47 - $153.48 $6,806 - $7,827
-51 Reduced 0.45%
11,383 $1.75 Million
Q3 2019

Oct 18, 2019

BUY
$135.4 - $146.47 $46,848 - $50,678
346 Added 3.12%
11,434 $1.65 Million
Q2 2019

Jul 24, 2019

SELL
$124.88 - $143.73 $72,680 - $83,650
-582 Reduced 4.99%
11,088 $1.59 Million
Q1 2019

Apr 29, 2019

SELL
$97.62 - $132.29 $266,990 - $361,813
-2,735 Reduced 18.99%
11,670 $1.54 Million
Q4 2018

Feb 11, 2019

SELL
$94.85 - $109.54 $302,381 - $349,213
-3,188 Reduced 18.12%
14,405 $1.49 Million
Q1 2018

May 03, 2018

BUY
$92.16 - $103.8 $11,980 - $13,494
130 Added 0.74%
17,593 $1.72 Million
Q4 2017

Feb 14, 2018

BUY
$85.26 - $94.62 $599,036 - $664,800
7,026 Added 67.32%
17,463 $1.62 Million
Q3 2017

Nov 09, 2017

BUY
$79.29 - $88.45 $827,549 - $923,152
10,437
10,437 $895,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $167B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Zeke Capital Advisors, LLC Portfolio

Follow Zeke Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zeke Capital Advisors, LLC with notifications on news.